Indivior Pharmaceuticals (INDV) said Monday it has completed its redomiciliation to the US from the UK to enhance its US capital markets footprint and raise equity indexation.
Under the redomiciliation, Indivior Pharmaceuticals becomes the new parent company of Indivior PLC, which has been renamed as Indivior Ltd., according to the company.
Indivior said its common shares will trade on Nasdaq under the current "INDV" ticker.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.